Status:
UNKNOWN
Repetitive Transcranial Magnetic Stimulation(rTMS) in the Treatment of Depression
Lead Sponsor:
Samsung Medical Center
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
Brief Summary
The objective of this study is to investigate the antidepressant efficacy of rTMS, and to assess cortical metabolism before and after rTMS sessions in patients with major depression. We also aimed to ...
Detailed Description
The specific aims of this study is to: (1) evaluate the antidepressant efficacy of rTMS on major depression; (2) evaluate the effects of rTMS on cognitive function in depressive patients; (3) assess t...
Eligibility Criteria
Inclusion
- Twenty patients fulfilling the diagnostic criteria of major depression according to DSM IV will be enrolled in the study.
- Antidepressant medication will be maintained throughout the study period.
Exclusion
- Exclusion criteria are current neurological or other psychiatric disorders, as well as a history of epileptic seizures, substantial brain damage or neurosurgical operation, according to established safety criteria.
- To exclude the effect of drug changes on post-rTMS cerebral glucose metabolism, the combinations and dosage of pre-rTMS antidepressant drugs will remain unchanged until the post-rTMS 18FDG PET is done.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01198561
Start Date
February 1 2006
End Date
December 1 2016
Last Update
December 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Kangnam-Ku, South Korea, 135-710